Literature DB >> 9712554

High sensitivity of Deinococcus radiodurans to photodynamically-produced singlet oxygen.

M Schäfer1, C Schmitz, G Horneck.   

Abstract

PURPOSE: To study the sensitivity of two bacterial cell systems to photodynamic treatment and X-ray irradiation as part of a project to establish efficient procedures for waste water disinfection.
MATERIALS AND METHODS: Stationary-phase cells of Deinococcus radiodurans (Gram-positive) and Escherichia coli (Gram-negative) were exposed to visible light in a buffer solution containing up to 5 microg/ml sensitizer rose bengal (RB) and to X-rays at dose rates of 32.8 Gy/min or 14.6 Gy/min, respectively.
RESULTS: Survival of both cell types decreased with increasing exposure time to visible light and increasing concentration of RB, and therefore with an increase in singlet oxygen production. Surprisingly, D. radiodurans, the most resistant cell system to ionizing radiation, was more sensitive to photodynamic treatment than E. coli by about a factor of 100.
CONCLUSIONS: The main target of singlet oxygen reaction is the cell membrane. The repair of such damage in D. radiodurans is less effective than in E. coli.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9712554     DOI: 10.1080/095530098141636

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  19 in total

1.  Photodynamic therapy: a new antimicrobial approach to infectious disease?

Authors:  Michael R Hamblin; Tayyaba Hasan
Journal:  Photochem Photobiol Sci       Date:  2004-02-12       Impact factor: 3.982

Review 2.  [Antibacterial photodynamic therapy. A new treatment for superficial bacterial infections?].

Authors:  T Maisch; R-M Szeimies; N Lehn; C Abels
Journal:  Hautarzt       Date:  2005-11       Impact factor: 0.751

Review 3.  Oxidative stress resistance in Deinococcus radiodurans.

Authors:  Dea Slade; Miroslav Radman
Journal:  Microbiol Mol Biol Rev       Date:  2011-03       Impact factor: 11.056

4.  Mechanistic aspects of the photodynamic inactivation of vancomycin-resistant Enterococci mediated by 5-aminolevulinic acid and 5-aminolevulinic acid methyl ester.

Authors:  Chengcheng Liu; Yingli Zhou; Li Wang; Lei Han; Jin'e Lei; Hafiz Muhammad Ishaq; Jiru Xu
Journal:  Curr Microbiol       Date:  2014-12-13       Impact factor: 2.188

5.  Protein oxidation and DNA repair inhibition by 6-thioguanine and UVA radiation.

Authors:  Quentin Gueranger; Feng Li; Matthew Peacock; Annabel Larnicol-Fery; Reto Brem; Peter Macpherson; Jean-Marc Egly; Peter Karran
Journal:  J Invest Dermatol       Date:  2013-11-27       Impact factor: 8.551

6.  Antimicrobial photodynamic therapy: study of bacterial recovery viability and potential development of resistance after treatment.

Authors:  Anabela Tavares; Carla M B Carvalho; Maria A Faustino; Maria G P M S Neves; João P C Tomé; Augusto C Tomé; José A S Cavaleiro; Angela Cunha; Newton C M Gomes; Eliana Alves; Adelaide Almeida
Journal:  Mar Drugs       Date:  2010-01-20       Impact factor: 5.118

7.  Effects of antimicrobial photodynamic therapy on antibiotic-resistant Escherichia coli.

Authors:  Aguinaldo S Garcez; Mohammed Kaplan; Grant J Jensen; Fábio R Scheidt; Eduardo M Oliveira; Selly S Suzuki
Journal:  Photodiagnosis Photodyn Ther       Date:  2020-09-24       Impact factor: 3.631

8.  Contact-free cold atmospheric plasma treatment of Deinococcus radiodurans.

Authors:  Tim Maisch; Tetsuji Shimizu; Anindita Mitra; Julia Heinlin; Sigrid Karrer; Yang-Fang Li; Gregor Morfill; Julia L Zimmermann
Journal:  J Ind Microbiol Biotechnol       Date:  2012-05-15       Impact factor: 3.346

Review 9.  Anti-microbial photodynamic therapy: useful in the future?

Authors:  Tim Maisch
Journal:  Lasers Med Sci       Date:  2006-11-21       Impact factor: 2.555

10.  Fast and effective photodynamic inactivation of multiresistant bacteria by cationic riboflavin derivatives.

Authors:  Tim Maisch; Anja Eichner; Andreas Späth; Anita Gollmer; Burkhard König; Johannes Regensburger; Wolfgang Bäumler
Journal:  PLoS One       Date:  2014-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.